The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients

Biomedicine and Pharmacotherapy

Volumn 75, Issue , 2015, Pages 8-11

  Deng, Jun ^a   Liang, Yujia ^a   Liu, Chunfeng ^a   He, Shengdong ^a   Wang, Songping ^a  

^a First Affiliated Hospital of Luzhou Medical College   (China)

Author keywords

LncRNA AFAP1 AS1; Non small cell lung cancer; Prognosis

Indexed keywords

LONG UNTRANSLATED RNA; AFAP1-AS1 LONG NONCODING RNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; SMOKING;

BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; RNA, LONG NONCODING; SMOKING; UP-REGULATION;

EID: 84944039839     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.07.003     Document Type: Article

References (26)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62(1):10-29.
2. Jemal A., et al. Global cancer statistics. CA Cancer J. Clin. 2011, 61(2):69-90.
3. Rapp U.R., et al. MYC is a metastasis gene for non-small-cell lung cancer. PLoS ONE 2009, 4(6):e6029.
4. Youlden D.R., Cramb S.M., Baade P.D. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J. Thorac. Oncol. 2008, 3(8):819-831.
5. Raungrut P., et al. Prognostic significance of 14-3-3gamma overexpression in advanced non-small cell lung cancer. Asian Pac. J. Cancer Prev. 2014, 15(8):3513-3518.
6. Bu D., et al. NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res. 2012, 40(Database issue):D210-D215.
7. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12(12):861-874.
8. Tsai M.C., Spitale R.C., Chang H.Y. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011, 71(1):3-7.
9. Wu W., et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2013, 144(5):956-966. e4.
10. Baisden J.M., et al. The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity. Oncogene 2001, 20(44):6435-6447.
11. Ye Y., et al. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma. J. Transl. Med. 2015, 13(1):137.
12. Yu H., et al. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas. J. Thorac. Oncol. 2015, 10(4):645-654.
13. Qiu M., et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol. 2014, 35(6):5375-5380.
14. Pastorino U. Lung cancer screening. Br. J. Cancer 2010, 102(12):1681-1686.
15. Chen J., et al. Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets. J. Cell. Mol. Med. 2014, 18(12):2425-2436.
16. Liu X.H., et al. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 2013, 13:464.
17. Zhang E.B., et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 2014, 5:e1243.
18. Xie X., et al. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Int. J. Clin. Exp. Pathol. 2014, 7(12):8881-8886.
19. Yang Y.R., et al. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 2014, 7(10):6929-6935.
20. Sun M., et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol. Cancer 2014, 13:68.
21. Hu T., Lu Y.R. BCYRN1, a c-MYC-activated long non-coding RNA, regulates cell metastasis of non-small-cell lung cancer. Cancer Cell Int. 2015, 15:36.
22. Han L., et al. Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2. Cell Death Dis. 2015, 6:e1665.
23. Cesana M., et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147(2):358-369.
24. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10(3):155-159.
25. Pao W., Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol. 2011, 12(2):175-180.
26. Yarmishyn A.A., Kurochkin I.V. Long noncoding RNAs: a potential novel class of cancer biomarkers. Front. Genet. 2015, 6:145.